Latest Breaking News On - Williamh collier - Page 2 : comparemela.com

Arbutus Announces Three Poster Presentations with Clinical Data from AB-729 and Preclinical Data from AB-101 at AASLD - The Liver Meeting® 2022

Conference Call and Webcast to discuss the new data being presented at AASLD scheduled for 8:45 AM ET, Friday, November 4, 2022

Arbutus to Report Third Quarter 2022 Financial Results and Provide Corporate Update

WARMINSTER, Pa., Oct. 26, 2022 (GLOBE NEWSWIRE) Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its…

Arbutus Biopharma Announces Issuance of a New Key U.S. Patent Related to AB-729

WARMINSTER, Pa., Aug. 30, 2022 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target. | August 30, 2022

Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update

Arbutus to Present Seven Scientific Posters at EASL International Liver Congress™ 2022 - Press Release

Conference Call & Webcast to discuss new data being presented at EASL ILC 2022 scheduled for June 27, 2022 at 8:00 am ETWARMINSTER, Pa., June 07,